Christopher Huang , M.D.
20 years of experience in the industry in medical practice and research,
pharmaceutical R&D, sales and marketing, and general
management at country
and regional management level in Australia, China and Singapore
Medical director, AstraZeneca Singapore
Medical director, Bayer China
Asia Pacific Regional BD Director, Covance Australia
Vice President, a JV CRO company with PharmaNet, China
National Hospital Business Manager, Air Liquide Healthcare, Australia
National Sales Manager, Upjohn China
Hematology Business Manager, Gradipore Ltd, Australia
Medical practice and post-graduate research in China and Australia
Under Dr Huang's leading, there have been many milestone clinical trials
and regulatory projects initiated and completed successfully in the region.
Among them, there have been several phase I, II, III and IV projects
including global trial with up to over 2,000 patients.
Dr Huang is also an active speaker and chairperson in global and regional
conferences on R&D topics.
Dr JP LING, MD (Beijing China)
Physician/Researcher
Head of Pathology Dept, National Institute for the Control of Pharmaceutical and Biological Products, China.
Head of Clinical Division, Center for Drug Evaluation, Ministry of Public Health; Head of Import Drug Division, Center for Drug Evaluation, State Drug Administration, China
Senior Consultant, a major pharmaceutical company & a CRO company
30 years of clinical, academic, regulatory and industry experience
Dr Frank Hu, MD (Beijing China)
Physician/Researcher
Managers/GMs, pharmaceutical and biotech companies, ie GE Medical, Upjohn and China MedEquipt
15 years of clinical and industry experience
Dr M Yao, MD, PhD (Sydney Australia)
Physician/Researcher, hospitals and universities in China, Australia and USA
21 years of clinical and academic research
Tomas Jia (Shanghai China)
Pharmacist/Researcher
Managers, pharmaceutical companies ie Boehringer Ingelheim, Upjohn and BDP.
14 years of industry experience
|
